By Najat Kantouar BioNTech said that it has agreed to invest $200 million in Autolus Therapeutics, starting a strategic collaboration to advance its pipeline.
By Najat Kantouar BioNTech said that it has agreed to invest $200 million in Autolus Therapeutics, starting a strategic collaboration to advance its pipeline and expand late-stage programs.
SYDNEY (Reuters) - BioNTech SE, the German biotech that developed a widely used COVID-19 vaccine with Pfizer Inc, will set up research and manufacturi.
Three doses of a Covid vaccine may not be able to curb the rapid spread of the highly transmissible Omicron variant of Covid, warned Ugur Sahin, CEO of Germany-based BioNTech, which is developing a vaccine to curb Omicron variant now